GlaxoSmithKline (GSK) stock forecast for 2025. Forecast tables and graphs.

GlaxoSmithKline (GSK) stock forecast for 2025

The forecast has been updated: September 15, 2021 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

48.04

Dividend Date

07.10.2021

Ex Dividend Date

19.08.2021

Last Split Factor

2:1

Last Split Date

12.11.1991

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $48.04 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the support level (38.71 $).

50 Day Moving Average is the support level (40.82 $).




GSK Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 42.28 41.44 43.09 3.83 %
Feb 42.84 42.48 43.83 3.09 %
Mar 42.04 41.42 43.32 4.39 %
Apr 42.09 41.43 43.17 4.03 %
May 41.79 40.62 42.25 3.86 %
Jun 41.75 41.39 42.87 3.46 %
Jul 41.22 40.10 41.76 3.97 %
Aug 40.45 39.76 40.93 2.85 %
Sep 41.83 41.48 42.25 1.81 %
Oct 42.87 41.63 43.54 4.38 %
Nov 44.47 43.12 45.17 4.53 %
Dec 43.61 42.57 44.64 4.65 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization

98 559 550 000 $

EBITDA

10 695 000 000

PE Ratio

14.76

PEG Ratio

3.449

Dividend Per Share

0.8

Dividend Yield

0.0201

EPS

2.406

Quarterly Earnings Growth YOY

-0.387

Quarterly Revenue Growth YOY

0.061

Trailing PE

16.38

Forward PE

12.55

EV To Revenue

3.927

EV To EBITDA

12.17

52 Week High

42.14

52 Week Low

31.42

50 Day Moving Average

40.82

200 Day Moving Average

38.71

Shares Outstanding

2515870000

Shares Float

2446669000

Shares Short Prior Month

15037900

Short Ratio

5.2

Percent Insiders

0.014

Percent Institutions

13.04

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 42.28. Negative monthly dynamics of the instrument is expected with 3.827% volatility is expected.

Pessimistic forecast: 41.44

Optimistic: 43.09


GlaxoSmithKline stock forecast for Feb 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 42.84. Positive monthly dynamics of the instrument is expected with 3.088% volatility is expected.

Pessimistic forecast: 42.48

Optimistic: 43.83


GlaxoSmithKline stock forecast for Mar 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 42.04. Negative monthly dynamics of the instrument is expected with 4.390% volatility is expected.

Pessimistic forecast: 41.42

Optimistic: 43.32


GlaxoSmithKline stock forecast for Apr 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 42.09. Positive monthly dynamics of the instrument is expected with 4.030% volatility is expected.

Pessimistic forecast: 41.43

Optimistic: 43.17


GlaxoSmithKline stock forecast for May 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 41.79. Negative monthly dynamics of the instrument is expected with 3.858% volatility is expected.

Pessimistic forecast: 40.62

Optimistic: 42.25


GlaxoSmithKline stock forecast for Jun 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 41.75. Negative monthly dynamics of the instrument is expected with 3.456% volatility is expected.

Pessimistic forecast: 41.39

Optimistic: 42.87


GlaxoSmithKline stock forecast for Jul 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 41.22. Negative monthly dynamics of the instrument is expected with 3.966% volatility is expected.

Pessimistic forecast: 40.10

Optimistic: 41.76


GlaxoSmithKline stock forecast for Aug 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 40.45. Negative monthly dynamics of the instrument is expected with 2.853% volatility is expected.

Pessimistic forecast: 39.76

Optimistic: 40.93


GlaxoSmithKline stock forecast for Sep 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 41.83. Positive monthly dynamics of the instrument is expected with 1.814% volatility is expected.

Pessimistic forecast: 41.48

Optimistic: 42.25


GlaxoSmithKline stock forecast for Oct 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 42.87. Positive monthly dynamics of the instrument is expected with 4.378% volatility is expected.

Pessimistic forecast: 41.63

Optimistic: 43.54


GlaxoSmithKline stock forecast for Nov 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 44.47. Positive monthly dynamics of the instrument is expected with 4.531% volatility is expected.

Pessimistic forecast: 43.12

Optimistic: 45.17


GlaxoSmithKline stock forecast for Dec 2025.
Estimated Average Forecasted GlaxoSmithKline Price: 43.61. Negative monthly dynamics of the instrument is expected with 4.647% volatility is expected.

Pessimistic forecast: 42.57

Optimistic: 44.64



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.44 (16.09.2021) -0.04 %
AbbVie Inc.
ABBV 108.08 (16.09.2021) 0.29 %
Aeterna Zentaris Inc.
AEZS 0.6143 (16.09.2021) -0.73 %
Allakos Inc.
ALLK 105.77 (16.09.2021) -2.27 %
Allogene Therapeutics, Inc.
ALLO 24.51 (16.09.2021) -1.96 %
Amgen Inc.
AMGN 217.36 (16.09.2021) -0.35 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.87 (16.09.2021) -0.19 %
Aurora Cannabis Inc.
ACB 6.62 (16.09.2021) -0.90 %
Becton Dickinson and Company
BDX 262.67 (16.09.2021) 0.38 %
Biogen Inc.
BIIB 299.69 (16.09.2021) 0.16 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 136.93 (16.09.2021) 0.69 %
BioNTech SE
BNTX 372.65 (16.09.2021) 4.90 %
bluebird bio, Inc.
BLUE 17.68 (16.09.2021) -0.67 %
Boston Scientific Corp.
BSX 44.9 (16.09.2021) -0.24 %
Bristol-Myers Squibb Company
BMY 61.23 (16.09.2021) -1.24 %
Canopy Growth Corp.
CGC 14.83 (16.09.2021) 0.27 %
Castle Biosciences, Inc.
CSTL 76.21 (16.09.2021) 1.99 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.14 (16.09.2021) -0.37 %
Eli Lilly and Company
LLY 231.04 (16.09.2021) -1.15 %
Emergent BioSolutions Inc.
EBS 57.47 (16.09.2021) 0.56 %
Exelixis, Inc.
EXEL 20.54 (16.09.2021) 0.34 %
G1 Therapeutics, Inc.
GTHX 14.27 (16.09.2021) 2.37 %
Gilead Sciences, Inc.
GILD 71.33 (16.09.2021) -0.60 %
GlaxoSmithKline plc
GSK 39.11 (16.09.2021) -0.28 %
GoodRx Holdings, Inc.
GDRX 45.93 (16.09.2021) 3.70 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.04 (16.09.2021) 2.18 %
Inovio Pharmaceuticals, Inc.
INO 7.75 (16.09.2021) 2.38 %
Johnson & Johnson
JNJ 165.22 (16.09.2021) -0.12 %
Medtronic plc.
MDT 130.92 (16.09.2021) -0.55 %
Merck & Co., Inc.
MRK 71.97 (16.09.2021) -1.15 %
Moderna, Inc.
MRNA 440.65 (16.09.2021) 1.42 %
Novartis AG
NVS 84.38 (16.09.2021) -0.82 %
Novavax, Inc.
NVAX 237.27 (16.09.2021) 2.14 %
ObsEva SA
OBSV 3.08 (16.09.2021) 0.65 %
OrganiGram Holdings Inc.
OGI 2.4 (16.09.2021) -0.83 %
Pfizer Inc.
PFE 44.47 (16.09.2021) -0.67 %
Regeneron Pharmaceuticals, Inc.
REGN 653.18 (16.09.2021) 0.18 %
Sanofi
SNY 48.19 (16.09.2021) 0.37 %
Schrodinger, Inc.
SDGR 61.15 (16.09.2021) 0.30 %
Senseonics Holdings, Inc.
SENS 3.82 (16.09.2021) -1.29 %
Sorrento Therapeutics, Inc.
SRNE 8.08 (16.09.2021) 1.76 %
Stryker Corp.
SYK 276.11 (16.09.2021) -0.36 %
Sundial Growers Inc.
SNDL 0.7193 (16.09.2021) -1.44 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (16.09.2021) -0.22 %
Thermo Fisher Scientific Inc.
TMO 560.44 (16.09.2021) -0.45 %
Tilray, Inc.
TLRY 12.01 (16.09.2021) -0.17 %
UnitedHealth Group, Inc.
UNH 416.84 (16.09.2021) -0.16 %
Veeva Systems Inc.
VEEV 305 (16.09.2021) 1.75 %
Zomedica Corp.
ZOM 0.5393 (16.09.2021) 1.56 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.32 (16.09.2021) -0.69 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.